Citizens Financial Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-124,177
Closed -$497K 869
2025
Q4
$497K Buy
124,177
+102,889
+483% +$572K 0.01% 543
2025
Q3
$180K Sell
21,288
-45
-0.2% -$437 ﹤0.01% 773
2025
Q2
$240K Sell
21,333
-67
-0.3% -$615 ﹤0.01% 630
2025
Q1
$203K Buy
21,400
+5,668
+36% +$57.3K ﹤0.01% 590
2024
Q4
$177K Buy
+15,732
New +$276K ﹤0.01% 565

Other funds holding EVH

Citizens Financial Group's EVH Position: Q1 2026 in Review

Citizens Financial Group sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 124,177 shares — an estimated $497K sold.

Citizens Financial Group first reported a position in EVH in Q4 2024 and held it in 5 quarters. The position peaked at $497K in Q4 2025. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Citizens Financial Group reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Citizens Financial Group sold 124,177 Evolent Health shares in Q1 2026, an estimated $497K.
  • Citizens Financial Group first reported a position in Evolent Health in Q4 2024 and held it in 5 quarters.
  • Citizens Financial Group's Evolent Health position peaked at $497K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.